Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.795 USD | -6.53% | +14.48% | +16.06% |
Jun. 03 | Omeros Corporation announced that it expects to receive $92.1 million in funding | CI |
May. 16 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
Chart calendar Omeros Corporation
Upcoming events on Omeros Corporation
Past events on Omeros Corporation
2024-05-15 04:30 pm | Q1 2024 Earnings Call |
2024-05-15 04:02 pm | Q1 2024 Earnings Release |
2024-04-01 04:30 pm | Q4 2023 Earnings Call |
2024-04-01 04:02 pm | Q4 2023 Earnings Release |
2024-02-22 07:45 pm | American Society for Transplantation and Cellular Therapy and Center for International Blood and Mar |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract #4082 |
2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract Number :3543 |
2023-12-10 08:00 pm | American Society of Hematology Meeting - Abstract #573 |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:02 pm | Q3 2023 Earnings Release |
2023-10-16 08:30 am | NARSOPLIMAB Phase 3 Study Results Call |
2023-08-09 08:30 am | Q2 2023 Earnings Call |
2023-08-09 08:00 am | Q2 2023 Earnings Release |
2023-06-23 01:00 pm | Annual General Meeting |
2023-06-11 03:45 am | European Hematology Association Hybrid Congress - Abstract No:LB2714 |
2023-06-09 12:00 pm | European Hematology Association Hybrid Congress - Abstract No: P787 |
2023-05-09 04:30 pm | Q1 2023 Earnings Call |
2023-05-09 04:02 pm | Q1 2023 Earnings Release |
2023-03-13 04:30 pm | Q4 2022 Earnings Call |
2023-03-13 04:02 pm | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 112 110 1.48% | 73,8 78,1 -5.47% | 112 111 0.95% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -109 -102 -6.57% | -172 0,41 -42182.49% | -162 -158 -2.7% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -63,4 -51,2 -23.84% | -111 -110 -0.42% | -174 -52,4 -231.55% | -163 -162 -1.16% | -165 -171 3.87% | -171 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -84,5 -72,3 -16.86% | -150 -150 -0.09% | -192 -84,2 -127.54% | -182 -111 -64.43% | -175 -150 -17% | -178 |
Net income Million USD | Released Forecast Spread | -84,5 -72,3 -16.86% | -138 -146 5.62% | 194 -84,1 330.92% | 47,4 -112 142.41% | -118 -147 19.99% | -154 |
EPS USD | Released Forecast Spread | -1,71 -1,52 -12.5% | -2,41 -2,51 4.17% | 3,12 -1,09 384.99% | 0,76 -1,81 141.96% | -1,88 -2,28 17.36% | -2,41 |
Announcement Date | 02/03/20 | 01/03/21 | 01/03/22 | 13/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,79 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -35,0 -44,4 21.12% | -37,4 -40,0 6.5% | -50,8 -36,8 -38.14% | -40,1 -41,0 2.12% | -35,7 -39,1 8.71% | -40,9 -38,5 -6.15% | -48,2 -43,2 -11.59% | -39,8 -46,3 14.02% | -39,0 -36,2 -7.98% | -47,6 | -42,5 | -42,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,0 -43,3 23.76% | -41,7 -36,0 -15.82% | -54,8 -36,0 -52.28% | -46,0 -29,3 -57.16% | -39,7 -35,3 -12.42% | -44,3 -33,7 -31.44% | -51,7 -42,6 -21.26% | -39,3 -40,8 3.71% | -43,9 -33,3 -31.68% | -55,6 | -42,5 | -42,3 |
Net income Million USD | Released Forecast Spread | -33,0 -43,3 23.76% | -30,8 -39,2 21.22% | -17,5 -37,8 53.88% | 129 -34,7 471.02% | -33,7 -35,3 4.53% | -37,3 -41,7 10.67% | -37,8 -42,6 11.38% | -9,07 -38,4 76.39% | -37,2 -33,7 -10.5% | -43,3 | -37,8 | -36,7 |
EPS USD | Released Forecast Spread | -0,53 -0,62 13.82% | -0,49 -0,63 22.2% | -0,28 -0,56 49.89% | 2,05 -0,57 457.27% | -0,54 -0,54 0.06% | -0,59 -0,57 -3.51% | -0,60 -0,65 6.98% | -0,15 -0,56 72.97% | -0,63 -0,56 -12.5% | -0,70 | -0,58 | -0,54 |
Announcement Date | 10/05/22 | 09/08/22 | 09/11/22 | 13/03/23 | 09/05/23 | 09/08/23 | 09/11/23 | 01/04/24 | 15/05/24 | - | - | - |
Past sector events for Omeros Corporation
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OMER Stock
- Calendar Omeros Corporation